Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study
Juan Xia, Chunyue Guo, Kuo Liu, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Lipoprotein(a)—60 Years Later—What Do We Know?
Anna Pasławska, Przemysław Tomasik
Cells (2023) Vol. 12, Iss. 20, pp. 2472-2472
Open Access | Times Cited: 16
Association Between Lipoprotein (a) and Risk of Atrial Fibrillation: A Systematic Review and Meta-analysis of Mendelian Randomization Studies
Sandeep Singh, Daniël P Baars, Rupak Desai, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102024-102024
Open Access | Times Cited: 15
The role of lipoprotein(a) in atrial fibrillation: a systematic review
Grzegorz Procyk, Marcin Grabowski, Aleksandra Gąsecka
Polskie Archiwum Medycyny Wewnętrznej (2025)
Open Access
The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
Hiroyuki Itabe, Takashi Obama
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5747-5747
Open Access | Times Cited: 12
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Low lipoprotein(a) concentration is associated with atrial fibrillation: a large retrospective cohort study
Junjie Tao, Xinlei Yang, Qingkai Qiu, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Exploring the role of lipoprotein(a) in cardiovascular diseases and diabetes in Chinese population
Zubair Hussain, Junaid Iqbal, Hongcai Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 233, pp. 123586-123586
Open Access | Times Cited: 7
Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review
Hesham Abdalla, Ahmed Mahmoud, Ahmed Khedr, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11029-11029
Open Access | Times Cited: 2
The association between lipoprotein(a) and atrial fibrillation: A systemic review and meta‐analysis
M. Yang, Basma Nasr, Junzhao Liu, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 899-905
Open Access | Times Cited: 6
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
Alessandro Maloberti, Saverio Fabbri, Valentina Colombo, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 170-170
Open Access | Times Cited: 10
Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies
Sandeep Singh, Daniël P Baars, Kanishk Aggarwal, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102439-102439
Open Access | Times Cited: 1
Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China
Pingting Yang, Li Tang, Huirong Guo, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Prognostic impact of lipoprotein(a) in patients undergoing percutaneous coronary intervention modified by low density lipoprotein cholesterol
Na Xu, Deshan Yuan, Yi Yao, et al.
Clinica Chimica Acta (2023) Vol. 540, pp. 117217-117217
Closed Access | Times Cited: 2
Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
Walter Masson, Leandro Barbagelata, Juan Patricio Nogueira, et al.
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 3, pp. 267-267
Open Access | Times Cited: 2
Lipoprotein(a): Screening and Care of the High-Risk Cardiovascular Disease Patient
Elizabeth Matthews, Pamela J. Biernacki
The Journal for Nurse Practitioners (2024), pp. 105227-105227
Closed Access
Causal relationships between uremic metabolites or toxins and heart failure: Univariate and multivariate Mendelian randomization
Mingyu Wei, Xianjing Hu, Min Zhu, et al.
Medicine (2024) Vol. 103, Iss. 47, pp. e40614-e40614
Open Access
Lipoprotein(a) and Atrial Fibrillation: Mechanistic Insights and Therapeutic Approaches
Zixi Zhang, Bo Peng, Akedanmu Nuranmubieke, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 2, pp. 357-370
Open Access
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Émilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Circulating Levels of PCSK9, ANGPTL3 and Lp(a) in Stage III Breast Cancers
Émilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
Journal of clinical lipidology (2022) Vol. 16, Iss. 1, pp. e3-e4
Open Access
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
Research Square (Research Square) (2022)
Open Access
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
Research Square (Research Square) (2022)
Open Access
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top